Althea Group supplies pharmaceutical grade medicinal cannabis to patients in Australia and the UK, with plans to expand into Asia and Europe. They are a licensed producer, supplier and exporter of medicinal cannabis, and they are listed on the Australian Securities Exchange.
Education, access and management services about medicinal cannabis treatment, are also provided – geared towards healthcare professionals and eligible patients.
Althea Group’s medicinal cannabis products have their safety, consistency and quality ensured by a 509-step quality management programme called the Seed-to-Sale Certification. Their cannabis is greenhouse grown and manufactured by Aphria Inc, part owner of Althea and a licensed producer of medicinal cannabis in Canada.
Althea Group provides a free online service as part of their telehealth program. This simplifies the process and makes medicinal cannabis more accessible to patients, pharmacies and healthcare professionals.
Their step by step program allows healthcare professionals to access treatment plans with dosing and titration information for the Althea product being used. Patients can also record any feedback they might have at any point of their treatment plan. Healthcare professionals can also learn more about medicinal cannabis usage, safety and considerations through Medic, a free online education resource.
For more information, Althea Group can be contacted by phone at 1300702020 or emailed at [email protected] Australian pharmacies interested in stocking Althea medicinal cannabis products can do so through Anspec, national wholesaler and exporter of pharmaceuticals, medical and dental consumables and equipment.
Industry: Medical Cannabis
Sub Industry: Grower,Supplier,Importer,ASX-Listed
About (30 words): Althea Group (ASX:AGH) supplies medicinal cannabis products and operates a concierge platforms connecting patients with products.
Get the latest Australian cannabis news straight to your inbox every week.